EZH2 and metastatic prostate carcinoma: Significant reverse correlation between HNF1B and EZH2 protein levels was also readily identified by IHC analyses in 17 cases of in-house collection of metastatic prostate cancer samples (r = −0.672; P = 0.031; Fig. 1h).